What was the primary driver of the increase in net sales for the second quarter of 2004?

The primary driver of the increase in net sales was a combination of a 4.0% unit volume gain and the recent acquisition of GABA Holding AG, which contributed positively to sales in the European oral care segment. Despite a slight decrease in net selling prices, overall sales grew by 4.5%.

How did the acquisition of GABA Holding AG impact Colgate-Palmolive's financial position?

The acquisition of GABA Holding AG, completed on June 1, 2004, for approximately $844 million, significantly increased the company's assets, particularly goodwill and intangible assets. It also led to an increase in total liabilities, including long-term debt, to fund the purchase. GABA's operations were consolidated into the European segment, contributing to sales and volume growth.

What is the outlook for the company's profitability, and what factors are influencing it?

Profitability remains a focus, with operating profit increasing 5% in the second quarter. Key factors influencing profitability include continued volume growth, cost-reduction initiatives, and a shift towards higher-margin businesses. However, increased commercial investment in North America, higher commodity costs impacting pet nutrition margins, and restructuring charges are also noted as influencing factors.

What is the company's strategy regarding shareholder returns?

Colgate-Palmolive continues to prioritize shareholder returns through increasing common stock dividends and share repurchases. For the first half of 2004, dividends per share increased to $0.48, and the company repurchased shares, although it anticipates a decline in repurchase activity in the second half of the year, focusing on repaying debt incurred for the GABA acquisition.

CL 10-Q Quarterly Report Q2 FY2004 — Revenue, Net Income, EPS

Summary

Colgate-Palmolive Company reported solid financial results for the second quarter and the first half of 2004, demonstrating continued growth driven by both volume increases and strategic acquisitions. Net sales increased by 4.5% for the quarter and 5.5% for the first half compared to the prior year, fueled by a 4.0% and 3.5% unit volume gain, respectively. The acquisition of GABA Holding AG in June 2004 significantly bolstered the European oral care segment, contributing to overall sales growth. Profitability remained strong, with operating profit up 5% for the quarter and net income seeing a 4% increase. Diluted earnings per share also showed positive growth. Management highlighted the company's strategic focus on core Oral, Personal, and Home Care, and Pet Nutrition segments, emphasizing growth through innovation and operational efficiencies. Despite some pressures from increased commercial investment in North America and higher commodity costs affecting pet nutrition margins, the company demonstrated resilience. The balance sheet shows a substantial increase in cash and a significant rise in goodwill and intangible assets due to the GABA acquisition, alongside increased long-term debt. The company also continued its share repurchase program and dividend payments, underscoring its commitment to shareholder returns.

Key Highlights

1Net sales increased by 4.5% to $2,571.7 million in Q2 2004, driven by a 4.0% unit volume increase, with the GABA acquisition contributing positively.
2Diluted earnings per share rose 6% to $0.66 in Q2 2004, and 6% to $1.25 for the first six months of 2004, compared to the prior year.
3The acquisition of GABA Holding AG for approximately $844 million in June 2004 is a significant strategic move to strengthen the European oral care business.
4Operating profit increased 5% to $584.8 million in Q2 2004, maintaining a strong operating margin of 22.7% of sales.
5Gross profit margin improved slightly to 55.4% in Q2 2004 from 55.0% in Q2 2003, benefiting from a shift to higher-margin businesses and cost reduction initiatives.
6The company continued to manage its capital structure, increasing dividends per share and engaging in share repurchases, while also incurring increased debt related to the GABA acquisition.
7Restructuring activities are ongoing, primarily in Europe, Latin America, and Asia/Africa, to streamline operations, with associated charges and expected benefits.

COLGATE PALMOLIVE CO Quarterly Report for Q2 Ended Jun 30, 2004

Summary

Key Highlights

Frequently Asked Questions